Evonik Birmingham Laboratories is one of the more advanced life sciences manufacturing and development sites in Alabama and serves as a global center of excellence for biomaterials, drug delivery technologies, and medical device innovation. The campus provides fully integrated capabilities spanning research and development, process scale-up, contract development and manufacturing (COMO), commercial manufacturing (CMO), and aseptic fill/finish operations.
The site manufactures bioresorbable polymers, medical device components, and pharmaceutical drug products that support partners ranging from emerging biotechnology companies to many of the world’s leading pharmaceutical and medical device organizations. Birmingham Laboratories is also home to Evonik’s Medical Device Competence Center (MDCC), a global hub for the development of advanced biomaterials and application technologies.
Since becoming part of Evonik, the site has benefited from significant investments in manufacturing, analytical, and development capabilities, positioning Birmingham as a global destination for innovation in complex drug delivery and implantable medical technologies. Today, the site employs 273 highly skilled professionals across manufacturing, engineering, quality, regulatory, laboratory, and support functions.